Details for 2012706221

Up to date per 03.04.2026

Actions

Title / Product Name

AMORPHE (5-FLUOR-2-METHYL-3-CHINOLIN-2-YLMETHYLINDOL-1-YL) -ESSIGSÄURE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012706221

EP Publication Number

2697215

E-Number

948236

Language

PCT Number

EP12052504

Publication Date

19.02.2014 A

22.11.2017 B1

Registration Date

22.11.2017

AT Publication Date

15.12.2017

Application Date

14.02.2012

Registration Number

Priorities

07.03.2011

201103837

IPC

C07D 401/06 20060101AFI20120928BHEP

Maximum Duration of Protection

14.02.2032

Owner

Atopix Therapeutics Limited265 Strand London WC2R 1BHGB

Representative

HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEIMariahilfer Straße 501070 WienAT

Inventor

BETANCOURT, AimestherCorealis Pharma Inc. 200 Boulevard Armand Frappier Laval, Québec H7V 4A6CA

LEMIEUX, MarcCorealis Pharma Inc. 200 Boulevard Armand Frappier Laval, Québec H7V 4A6CA

THIBERT, RochCorealis Pharma Inc. 200 Boulevard Armand Frappier Laval, Québec H7V 4A6CA